These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7557890)

  • 1. Does interferon precipitate rejection of liver allografts?
    Min AD; Bodenheimer HC
    Hepatology; 1995 Oct; 22(4 Pt 1):1333-5. PubMed ID: 7557890
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation.
    Ueda Y; Kaido T; Ito T; Ogawa K; Yoshizawa A; Fujimoto Y; Mori A; Miyagawa-Hayashino A; Haga H; Marusawa H; Chiba T; Uemoto S
    Transplantation; 2014 Feb; 97(3):344-50. PubMed ID: 24157473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C, interferon, and risk of rejection after liver transplantation.
    Samuel D
    Liver Transpl; 2004 Jul; 10(7):868-71. PubMed ID: 15237370
    [No Abstract]   [Full Text] [Related]  

  • 4. An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection.
    Féray C; Samuel D; Gigou M; Paradis V; David MF; Lemonnier C; Reynès M; Bismuth H
    Hepatology; 1995 Oct; 22(4 Pt 1):1084-9. PubMed ID: 7557855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rejection of non-functional renal grafts in dialysis patients after starting treatment with interferon and ribavirin.
    Cavero-Escribano T; Morales-Ruiz E; Manzano-Peña MT; Muñoz-Gómez R; Hernández-Martínez E; Gutiérrez-Martínez E; Praga-Terente M
    Nefrologia; 2014; 34(2):230-4. PubMed ID: 24658199
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis C infection after liver transplantation.
    Alsatie M; Chalasani N; Kwo PY
    Drugs; 2007; 67(6):871-85. PubMed ID: 17428105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatitis C in the HIV-infected person].
    Teruya K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):682-7. PubMed ID: 15359885
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral agents in the treatment of chronic viral hepatitis.
    Perrillo RP
    Prog Liver Dis; 1992; 10():283-309. PubMed ID: 1284255
    [No Abstract]   [Full Text] [Related]  

  • 10. Consensus conference. Treatment of hepatitis C.
    Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES)
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B303-20. PubMed ID: 12180305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.
    Selzner N; Guindi M; Renner EL; Berenguer M
    J Hepatol; 2011 Jul; 55(1):207-17. PubMed ID: 21145865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C: ribavirin and/or interferon?
    Heathcote J
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S71-5. PubMed ID: 8986103
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Nakano R; Ohira M; Ishiyama K; Ide K; Kobayashi T; Tahara H; Shimizu S; Arihiro K; Imamura M; Chayama K; Tanaka Y; Ohdan H
    Transplant Proc; 2017 Sep; 49(7):1634-1638. PubMed ID: 28838454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha.
    Fischer L; Sterneck M; Valentin-Gamazo C; Feucht HH; Malagó M; Broelsch CE
    Transplant Proc; 1999; 31(1-2):494-5. PubMed ID: 10083207
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of acute rejection after interferon therapy in liver transplant recipients.
    Saab S; Kalmaz D; Gajjar NA; Hiatt J; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Goldstein LI; Lassman CR; Busuttil RW
    Liver Transpl; 2004 Jul; 10(7):859-67. PubMed ID: 15237369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation of methamphetamine abuse during interferon treatment.
    Lampinen TM; Greatheart MS; Schilder AJ; Kowdley K
    Am J Psychiatry; 2007 Sep; 164(9):1439. PubMed ID: 17728435
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha 2a.
    Sperl J; Petrasek J; Spicak J; Viklicky O
    J Hepatol; 2008 Sep; 49(3):461-2; author reply 462-3. PubMed ID: 18644649
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C.
    Fernández I; Ulloa E; Colina F; Abradelo M; Jiménez C; Gimeno A; Meneu JC; Lumbreras C; Solís-Herruzo JA; Moreno E
    Liver Transpl; 2009 Aug; 15(8):948-55. PubMed ID: 19642125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus among consensus conferences on management of hepatitis C: what we knew then and are still sure about, what we are newly sure about, and what we still need to know.
    Farrell GC
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E126-9. PubMed ID: 10921395
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on Fabrizi et al.: Treatment of hepatitis C after kidney transplant: A pooled analysis of observational studies.
    Pan YN; Luo YJ; He S
    J Med Virol; 2015 Aug; 87(8):1255. PubMed ID: 26037651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.